Stock listing
A3CY4J Stock Price, News, Filings & Events — Elicio Therapeutics, Inc.
Selected listing: A3CY4J · LSX · EUR · DE
This page tracks Elicio Therapeutics, Inc.'s A3CY4J:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CY4J:LSX. A3CY4J:LSX is the stock-level entry point for investors researching Elicio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3CY4J:LSX
- Asset type
- Stock
- Market cap
- $53.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Elicio Therapeutics, Inc. A3CY4J:LSX stock context
This page tracks Elicio Therapeutics, Inc.'s A3CY4J:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CY4J:LSX. A3CY4J:LSX is the stock-level entry point for investors researching Elicio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Elicio Therapeutics, Inc.
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
August 31, 2026
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
August 24, 2026
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 13, 2026
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
July 6, 2026
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
July 2, 2026
Research Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A3CY4J:LSX.
Elicio Therapeutics, Inc. company profile
View the public company page for Elicio Therapeutics, Inc. on 6ix.
Elicio Therapeutics, Inc. news
Read company news and market updates connected to Elicio Therapeutics, Inc..
Elicio Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Elicio Therapeutics, Inc..
Alternate listings
ELTX:NASDAQ
US · USD
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
ELTX:BOATS
US · USD
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
A3CY4J:LS
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
9HA:GETTEX
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
9HA:DUS
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
9HA:FWB
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
9HA:MUN
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.
9HA:TRADEGATE
DE · EUR
Alternate listing for Elicio Therapeutics, Inc.; the primary context on this page is A3CY4J:LSX.